share_log

上海市锦天城律师事务所关于上海谊众药业股份有限公司2022年限制性股票激励计划第一个归属期符合归属条件及调整2022年限制性股票激励计划相关事项的法律意见书

Legal Opinion of Shanghai AllBright Law Firm on matters relating to the first vesting period of the 2022 Restricted Stock Incentive Plan of Shanghai Yizhong Pharmaceutical Co., Ltd. meeting the conditions of ownership and the adjustment of the 2022 Restric

深证信a股 ·  Apr 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more